Durvalumab Intravenous and Insulin glargine and lixisenatide
Determining the interaction of Durvalumab Intravenous and Insulin glargine and lixisenatide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: durvalumab
Brand name: Imfinzi
Synonyms: Durvalumab
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Durvalumab Intravenous-Insulin glargine and lixisenatide Subcutaneous
- Durvalumab Intravenous-Insulin glargine, recombinant Subcutaneous
- Durvalumab Intravenous-Insulin glulisine
- Durvalumab Intravenous-Insulin Glulisine (Cartridges and Pens)
- Durvalumab Intravenous-Insulin Glulisine (Vials)
- Durvalumab Intravenous-Insulin glulisine Subcutaneous
- Insulin glargine and lixisenatide-Dutasteride
- Insulin glargine and lixisenatide-Dutasteride and tamsulosin
- Insulin glargine and lixisenatide-Dutasteride and Tamsulosin Capsules
- Insulin glargine and lixisenatide-Dutasteride Capsules
- Insulin glargine and lixisenatide-Dutoprol
- Insulin glargine and lixisenatide-Duvelisib